“To Anticipate”: Neoadjuvant Therapy in Melanoma with a Focus on Predictive Biomarkers

Despite surgical resection and adjuvant therapies, stage III melanomas still have a substantial risk of relapse. Neoadjuvant therapy is an emerging strategy that might offer superior efficacy compared to adjuvant therapy. Moreover, neoadjuvant therapy has some virtual advantages: it might allow for...

Descripción completa

Detalles Bibliográficos
Autores principales: Garutti, Mattia, Buriolla, Silvia, Bertoli, Elisa, Vitale, Maria Grazia, Rossi, Ernesto, Schinzari, Giovanni, Minisini, Alessandro Marco, Puglisi, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409214/
https://www.ncbi.nlm.nih.gov/pubmed/32708968
http://dx.doi.org/10.3390/cancers12071941

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409214/
https://www.ncbi.nlm.nih.gov/pubmed/32708968
http://dx.doi.org/10.3390/cancers12071941

Ejemplares similares